Kevin Hallgren, PhD
Personal Statement
I am a clinical psychologist with research interests in the treatment of alcohol and substance use disorders and co-occurring mental health conditions. My research focuses on understanding how to improve access to evidence-based treatments and understanding why and how patients benefit from treatment. I am particularly interested in research measurement-based care — i.e., the use of standardized measures to monitor treatment progress and inform clinical decision-making. Broad areas of interest include:- Alcohol and drug use disorder treatment, including the effectiveness of digital and behavioral interventions, mechanisms of behavioral change, and social and environmental determinants of change.
- Technology to support behavioral change, including patient- and clinician-facing tools that support clinical decision-making, treatment adherence, and treatment progress monitoring.
- Applied statistical analysis, including methods for analyzing longitudinal data, clinical trials data, multilevel data, missing data, psychometric analysis, and data visualization.
Education
PhD, Clinical Psychology, University of New Mexico, 2010-2014
Pre-Doctoral Psychology Internship, Southwest Consortium of Clinical Psychology Internships, 2013-2014
MS, Psychology, University of New Mexico, 2008-2010
BA, Psychology, University of Missouri, 2003-2007
Department Affiliations
Centers/Programs
Other Affiliations
Scholarly Expertise
- Access to health care
- Addiction
- Addiction psychiatry/psychology
- Alcohol Use Disorder (AUD)
- Biostatistics
- Collaborative Care / Integrated Care
- Depression
- Evidence-based practice
- Health behaviors
- Health services and health policy
- Human-centered design
- Implementation science
- Measurement-based care
- Medical records
- Mobile mental health
- Opioid Use Disorder (OUD)
- Patient-centered outcomes
- Pragmatic clinical trials
- Primary care
- Psychosocial outcomes
- Psychotherapies
- Randomized controlled trial
- Research methods
- Telemedicine
- Telepsychiatry/telepsychology
- AMPERE (Augmented Momentary Personal Ecological Risk Evaluation)
- Improving treatment strategies and clinical outcomes in patients with first-episode psychosis and substance use disorders
- Developing a hospital-based treatment engagement program for Alcohol Use Disorder
- Validating changes in a primary-care based alcohol use screening instrument for predicting changes in risk for psychiatric acute care utilization
- Partnering with the Quinault Indian Nation to develop a community-based contingency management intervention
- Improving the implementation of smartphone-based contingency management in medical settings for the treatment of methamphetamine use disorder: a qualitative analysis of patient and clinician experiences
- Acceptability and feasibility of a single-session + digital mental health intervention for people with psychosis on an acute psychiatric inpatient unit
- eHaRT-A: adapting an in-person harm reduction for alcohol intervention into a telehealth platform
- eHaRT-A
- Impact of the Preventing Addiction-Related Suicide (PARS) Intervention on patients who receive community-based addiction treatment
- Using routine alcohol screening measures to identify 1-year risk of suicidal ideation, intent, and planning within a large primary care system in Washington
- Understanding practical alcohol measures in primary care to prepare for measurement-based care
- Improving opioid use disorder treatment using contingency management via mHealth
- Developing measurement-based care tools for addiction treatment clinics
- Bolster: Development and testing of a caregiver-facing mobile health intervention to reduce duration of untreated psychosis
- Feasibility of mHealth technology-enabled service for remote observed therapy of methadone and COVID-19 screening for patients in an opioid treatment program
- The UW Medical Student Addiction Research (MedStAR) program to address substance use disorders in urban and rural communities in five western states
- Patient-centered team-based primary care to treat opioid use disorder, depression, and other conditions (PC2Too)
- Changing our paths: well-being and recovery among Native Americans with opioid use disorder
- Alcohol and addiction Research Domain Criteria (AARDoC) and alcohol use disorder recovery
- Validating a DSM-5 Substance Use Disorder (SUD) symptom checklist
Recent Publications
Hospital-Wide Implementation, Clinical Outcomes, and Safety of Phenobarbital for Alcohol Withdrawal.
(2025 Aug 1)
JAMA Netw Open 8(8): e2528694
Wolpaw BJ, Oren H, Quinnan-Hostein L, Bradley KA, Johnson NJ, Hallgren KA, Gupta A, Kim HN, Granich MA, Steel TL
(2025 Aug 1)
JAMA Netw Open 8(8): e2528694
Wolpaw BJ, Oren H, Quinnan-Hostein L, Bradley KA, Johnson NJ, Hallgren KA, Gupta A, Kim HN, Granich MA, Steel TL
The association between changes in AUDIT-C scores and acute mental healthcare utilization over the next year in a primary care population.
(2025 Aug 23)
Alcohol Clin Exp Res (Hoboken)
Lee ML, Jack HE, Matson TE, Oliver M, Bobb JF, Berger D, Bradley KA, Hallgren KA
(2025 Aug 23)
Alcohol Clin Exp Res (Hoboken)
Lee ML, Jack HE, Matson TE, Oliver M, Bobb JF, Berger D, Bradley KA, Hallgren KA
High-Dose Buprenorphine Treatment in the Setting of Fentanyl.
(2025 Aug 1)
JAMA Netw Open 8(8): e2528119
Tsui JI, Bhatraju EP, Hallgren KA, Rhew IC, Samet JH
(2025 Aug 1)
JAMA Netw Open 8(8): e2528119
Tsui JI, Bhatraju EP, Hallgren KA, Rhew IC, Samet JH
Prescribed medications for patients with amphetamine-type stimulant use disorder seen in rural-serving Pacific Northwest primary care clinics.
(2025 Aug 13)
Addict Sci Clin Pract 20(1): 67
Yerton MJ, McCabe CJ, Iles-Shih MD, Tsui JI, Hallgren KA
(2025 Aug 13)
Addict Sci Clin Pract 20(1): 67
Yerton MJ, McCabe CJ, Iles-Shih MD, Tsui JI, Hallgren KA
Hospital readmissions and emergency department encounters among patients who initiate medications for opioid use disorder during hospitalization: Comparison of patients with and without co-occurring methamphetamine use.
(2025 Oct)
J Subst Use Addict Treat 177(): 209765
Hallgren KA, Speaker E, Bhatraju EP, Iles-Shih M, Kennedy DN, Gojic AJ, Fotinos C, Merrill JO, Tsui JI
(2025 Oct)
J Subst Use Addict Treat 177(): 209765
Hallgren KA, Speaker E, Bhatraju EP, Iles-Shih M, Kennedy DN, Gojic AJ, Fotinos C, Merrill JO, Tsui JI
Show complete publication list »
